Frequency of occurrence and antimicrobial susceptibility of Gram-negative bacteremia isolates in patients with urinary tract infection: results from United States and European hospitals (2009–2011)
Authors:
- Helio S. SaderHSHelio S. Sader
- Robert K. FlammRFRobert K. Flamm
- Ronald N. JonesRJRonald N. Jones
- 6 December 2013
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 26 (3) , 133-138
Abstract
We evaluated the frequency of occurrence and antimicrobial susceptibility patterns of Gram-negative bacteria isolated from bacteremic patients with UTI from European (EU) and United States (USA) hospitals during a 3-year period (2009-2011). Susceptibility testing was performed by the reference broth microdilution method on 2071 Gram-negative bacilli. The most frequently isolated pathogens were Escherichia coli (63·3/71·3% in USA/EU), Klebsiella spp. (16·7/11·2%) and Proteus mirabilis (6·4/5·0%). Escherichia coli susceptibility rates were generally similar in the USA and EU, with extended-spectrum beta-lactamase (ESBL)-phenotype rates at 8·1% in both regions. Among Klebsiella spp., ESBL rates varied from 11·4/17·1% in 2009 to 16·1/40·4% in 2011 in USA/EU, and susceptibility rates were generally lower in EU compared to the USA. Pseudomonas aeruginosa exhibited lower susceptibility rates to ceftazidime, meropenem and piperacillin/tazobactam in EU (78·4, 78·4 and 76·5%, respectively) compared to USA (91·2, 88·2 and 91·2%, respectively). In summary, very few antimicrobials provided satisfactory coverage (>90%) when tested against Klebsiella spp. and P. aeruginosa isolates in EU.Keywords
This publication has 18 references indexed in Scilit:
- Risk Factors for Multidrug Resistance in Nosocomial Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniaeMicrobial Drug Resistance, 2012
- Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa BacteremiaAntimicrobial Agents and Chemotherapy, 2012
- Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaInternational Journal Of Clinical Practice, 2012
- Both Host and Pathogen Factors Predispose to Escherichia coli Urinary-Source Bacteremia in Hospitalized PatientsClinical Infectious Diseases, 2012
- Impact of Inadequate Empirical Therapy on the Mortality of Patients with Bloodstream Infections: a Propensity Score-Based AnalysisAntimicrobial Agents and Chemotherapy, 2012
- Diagnosis and Management of Urinary Tract Infection and PyelonephritisEmergency Medicine Clinics of North America, 2011
- Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infectionInfection, 2011
- Clinical significance of nosocomial acquisition in urinary tract–related bacteremia caused by gram-negative bacilliAmerican Journal of Infection Control, 2011
- Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemiaJournal of Antimicrobial Chemotherapy, 2007
- Risk factors for nosocomial urinary tract–related bacteremia: A case-control studyAmerican Journal of Infection Control, 2006